(Q40448031)

English

Fatty Acid Amide Hydrolase Inhibitor Treatment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Adaptive Double-blind, Randomized Controlled Trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Fatty Acid Amide Hydrolase Inhibitor Treatment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Adaptive Double-blind, Randomized Controlled Trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

0 references

0 references

Chronic prostatitis/chronic pelvic pain syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Florian M E Wagenlehner

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Jos G A Houbiers

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Reynaldo V Martina

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Dirk P Cerneus

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Joost H J M Melis

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Antoni Majek

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Egils Vjaters

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Michael Urban

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Henrikas Ramonas

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Daniel A Shoskes

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

J Curtis Nickel

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

language of work or name

0 references

publication date

27 February 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

103

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

191-197

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Understanding chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): the studies, the evidence, and the impact

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Modulation of transmitter release via presynaptic cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

The neurobiology and evolution of cannabinoid signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Inhibition of fatty acid amide hydrolase suppresses referred hyperalgesia induced by bladder inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Validation of the Patient Perception of Intensity of Urgency Scale in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Long-term Therapeutic Use of Benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Adaptive Designs for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Efficacy and tolerability of fesoterodine in men with overactive bladder: a pooled analysis of 2 phase III studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

The endocannabinoid system - a target for the treatment of LUTS?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2017.02.029

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.UROLOGY.2017.02.029

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28254462%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40448031&oldid=1533668621"